Spots Global Cancer Trial Database for camrelizumab ＋immunotherapy
Every month we try and update this database with for camrelizumab ＋immunotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Total Neoadjuvant Treatment ±Immunotherapy for High Risk Locally Advanced Rectal Cancer (TNTi) | NCT06229041 | Rectal Cancer | Camrelizumab ＋I... | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | |
| Total Neoadjuvant Treatment ±Immunotherapy for High Risk Locally Advanced Rectal Cancer (TNTi) | NCT06229041 | Rectal Cancer | Camrelizumab ＋I... | 18 Years - 75 Years | Peking University Cancer Hospital & Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
